
Eli Lilly and Co
LLYHealthcare|Drug Manufacturers - General|USA
$927.06
-8.52 (-0.91%)
DCF (FCF)
$74.80
Tangible Book
$15.77
Graham Number
$92.73
Earnings Power
$55.36
Analyst Ratings
| Firm / Analyst | Rating | Price Target | Date |
|---|---|---|---|
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — |
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812"
],
"revenue_estimate": [
81948.14,
94901.59,
107413.39
],
"ebit_estimate": [
38460.13,
45830.54,
53326.11
],
"ebitda_estimate": [
40494.1,
48246.61,
55956.18
],
"net_income_estimate": [
31024.96,
37676.52,
44102.08
],
"per_share_eps_estimate": [
34.15,
41.44,
48.27
],
"eps_nri_estimate": [
34.64,
42.16,
49.5
],
"dividend_estimate": [
6.83,
7.76,
8.29
],
"book_value_per_share_estimate": [
55.54,
86.03,
125.55
],
"pretax_income_estimate": [
37915.04,
46099.37,
54132.81
],
"operating_cash_flow_per_share_estimate": [
37.07,
43.91,
51.07
],
"roa_estimate": [
24.95,
25.75,
24.37
],
"roe_estimate": [
78.79,
59.61,
47.97
],
"gross_margin_estimate": [
83.16,
83.35,
83.51
],
"operating_cash_flow_estimate": [
33287.9,
39434.67,
45862.64
],
"pettm_estimate": [
27.15,
22.37,
19.2
],
"long_term_growth_rate_mean": 26.39,
"long_term_revenue_growth_rate_mean": "17.89",
"future_per_share_eps_estimate_growth": 27.43,
"future_eps_nri_estimate_growth": 26.39,
"future_revenue_estimate_growth": 17.89,
"future_ebit_estimate_growth": 21.31,
"future_ebitda_estimate_growth": 20.69,
"future_dividend_estimate_growth": 11.61,
"future_net_income_estimate_growth": 28.04,
"future_pretax_income_estimate_growth": 27.46,
"future_book_value_per_share_estimate_growth": 61.07,
"future_roa_estimate_growth": 4.02,
"future_roe_estimate_growth": -22.25,
"future_gross_margin_estimate_growth": 0.19,
"future_operating_cash_flow_per_share_estimate_growth": 37.49
}
quarterly
{
"date": [
"202603",
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
17440.93,
19516,
21310.06,
23676.63,
18900,
19820,
20600,
22055
],
"ebit_estimate": [
7933.65,
8951.44,
10133.16,
11275.56,
null,
null,
null,
null
],
"ebitda_estimate": [
8561.24,
9665.46,
10927.71,
11712.07,
null,
null,
null,
null
],
"net_income_estimate": [
6319.09,
7180.12,
8173.38,
9210.04,
8093,
8230,
8431,
8675
],
"per_share_eps_estimate": [
7.1,
8.14,
9.09,
9.83,
null,
null,
null,
null
],
"eps_nri_estimate": [
7.24,
8.11,
9.18,
10.13,
9.1,
9.93,
10.23,
4.6
],
"dividend_estimate": [
1.63,
1.63,
1.63,
1.63,
1.5,
1.5,
1.5,
1.5
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
7677.12,
8750.15,
10085.28,
11338.36,
null,
null,
null,
null
],
"operating_cash_flow_per_share_estimate": [
21.09,
26.86,
31.97,
36.02,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
84.1,
82.95,
82.8,
83.95,
84.5,
6,
84.6,
85
],
"operating_cash_flow_estimate": [
18940.93,
24122.97,
28712.26,
32345.07,
null,
null,
null,
null
],
"pettm_estimate": [
27.14,
null,
null,
null,
null,
null,
null,
null
],
"long_term_growth_rate_mean": 26.39,
"long_term_revenue_growth_rate_mean": "17.89",
"future_per_share_eps_estimate_growth": 27.43,
"future_eps_nri_estimate_growth": 26.39,
"future_revenue_estimate_growth": 17.89,
"future_ebit_estimate_growth": 21.31,
"future_ebitda_estimate_growth": 20.69,
"future_dividend_estimate_growth": 11.61,
"future_net_income_estimate_growth": 28.04,
"future_pretax_income_estimate_growth": 27.46,
"future_book_value_per_share_estimate_growth": 61.07,
"future_roa_estimate_growth": 4.02,
"future_roe_estimate_growth": -22.25,
"future_gross_margin_estimate_growth": 0.19,
"future_operating_cash_flow_per_share_estimate_growth": 37.49
}